Ayse Leyla Mindikoglu

Ayse Leyla Mindikoglu, M.D., M.P.H., is a Professor of Medicine at Baylor College of Medicine, specializing in the Section of Gastroenterology and Hepatology. She holds board certifications in Internal Medicine, Gastroenterology, and Transplant Hepatology, with over 18 years of academic clinical practice encompassing clinical care, research, and education.

Education:

• M.D., University of Istanbul, Cerrahpasa Faculty of Medicine (1995)
• M.P.H. (Epidemiology and Biostatistics), University of Maryland Baltimore (2007)
• Residencies: Internal Medicine (University of Istanbul), Gastroenterology/Hepatology (Bronx-Lebanon Hospital Center)
• Fellowships: Advanced Hepatology (Loyola University), Hepatology (University of Miami)

Research Interests: Dr. Mindikoglu's work focuses on dawn-to-dusk fasting, cirrhosis complications (ascites, hepatorenal syndrome), metabolic syndrome reversal, and non-alcoholic fatty liver disease. Her NIH-funded projects explore renal dysfunction biomarkers in cirrhosis and fasting-induced proteomic changes in metabolic disorders. She also investigates liver transplantation outcomes and immune responses in obesity-related conditions.

Publication Trends: Her 15 most recent articles (2010–2024) emphasize metabolic health, circadian fasting, cirrhosis biomarkers, and transplantation equity. Key themes include anti-inflammatory effects of fasting, gender disparities in liver allocation, and metabolomic signatures for hepatorenal dysfunction.

Awards & Honors:

• 2023: US National Academy of Medicine Catalyst Award, Norton Rose Fulbright Teaching Award
• 2022: Women of Excellence Award
• 2017–2021: Quadruple Roderick D. MacDonald Research Awards
• 2019: Fellow of AASLD
• 2010: NIH/NIDDK K23 Career Development Award

Grants & Advising: Primary funding includes NIH/NIDDK K23 (2010–2015) and Roderick D. MacDonald grants (2017–2021) for cirrhosis biomarker development. She mentors clinical researchers but lists no formal advisees in the provided text.